Balyasny Asset Management LLC Sorrento Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $40,596 - $100,393	54,860 Added 151.99%	90,954 $80,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $38,281 - $73,013	-25,352 Reduced 41.26%	36,094 $57,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $76,193 - $143,169	61,446 New	61,446 $124,000
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $27,610 - $67,644	-13,805 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $64,193 - $99,810	13,805 New	13,805 $64,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $96,939 - $152,660	-15,266 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $41,223 - $96,814	-5,864 Reduced 27.75%	15,266 $126,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $121,708 - $252,503	21,130 New	21,130 $144,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $207,536 - $437,788	-103,252 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $435,723 - $774,390	103,252 New	103,252 $454,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.